1.Study of changes of symptoms and life quality of patients after transvaginal tape-obturator operation
Chongqing Medicine 2013;(26):3102-3104
Objective To study the changes of the symptoms and quality of life in the patients after the transvaginal tape-obtura-tor(TVT-O) operation .Methods To retrospectively analyze the clinical data of 96 female patients with stress urinary incontinence (SUI) in our hospital from February 2007 to April 2012 .48 cases of retropubic tension free vaginal tape(TVT) were taken as the control group and 48 cases of TVT-O as the experimental group .The intraoperative general condition and postoperative symptoms changes and life quality were analyzed and compared between the two groups .Results The operation time ,blood loss and hospital stay time in the experimental group were significantly less than those in the control group (t=17 .061 ,17 .026 ,15 .465 ,P>0 .05) , the difference of operative effects between the two groups was not statistically significant (χ2 =0 .711 ,P>0 .05) .After treatment , all the patients′scores of quality of life were significantly improved compared with that before treatment (29 .1 ± 9 .6 ,30 .3 ± 9 .8 vs . 70 .4 ± 10 .2 ,68 .5 ± 11 .4 ,P<0 .05) ,but score differences between the two groups showed no statistical significance (P>0 .05) ,af-ter treatment ,the symptom scores and urinal pad use of two groups were obviously improved compared with those before treatment (13 .9 ± 2 .8 ,14 .1 ± 2 .5 vs .5 .1 ± 1 .2 ,5 .4 ± 1 .7 89 .6% ,93 .8% vs .50 .0% ,58 .3% ,P<0 .05) ,but the differences between the two groups were not statistically significant (P>0 .05) .Conclusion TVT-O can improve the symptoms and quality of life in the pa-tients with SUI .In the same time ,it has advantages of minimal invasion and low risk ,which is worth promoting ,but the surgeons need to accumulate more clinical experience .
2.Mid-term efficacy of Waveflex semi-rigid internal fixation system in the treatment of lumbar degenerative diseases
Kaiying CUI ; Wenming CHEN ; Guoyan LIU ; Ning YU ; Pengfei HOU ; Zhenyue ZHANG ; Yanke HAO
Chinese Journal of Orthopaedics 2021;41(17):1257-1266
Objective:To investigate the mid-term clinical efficacy and imaging changes of Waveflex semi-rigid internal fixation system combined with posterior lumbar interbody fusion (PLIF) in the treatment of double segmental lumbar degenerative diseases.Methods:The data of 51 patients with lumbar degenerative diseases who underwent surgery from September 2014 to September 2015 were retrospectively analyzed, including 29 males and 22 females, aged 65.5±5.6 years (range 58-73 years). Preoperative intervertebral space degeneration grade by University of California at Los Angeles (UCLA) and Pfirrmann intervertebral disc degeneration grade were recorded. 23 cases of primary responsible segments were treated with decompression, fixation and fusion, and adjacent secondary responsible or degenerative segments were treated with Waveflex semi-rigid internal fixation (combined group); 28 cases of double segments were treated with decompression, fixation and fusion (fusion group). Disc height index (DHI) and intervertebral foramina height (IFH) of the semi-rigid fixation segments, DHI and IFH of the upper adjacent intervertebral space, and horizontal displacement of the upper adjacent vertebral body (HD) were measured on lateral X-ray films of lumbar spine; In the fusion group, DHI and IFH adjacent to the upper vertebral space and HD adjacent to the upper vertebral body were measured. The efficacy was evaluated by short-form McGill Pain Questionnaire (SF-MPQ) and Oswestry disability index (ODI).Results:51 cases were followed up for 5.4±0.3 years (range 5.2-6.3 years). The low back and leg pain and function in the combined group and fusion group were significantly improved compared with those before operation. SF-MPQ and ODI at 3 months, 1 year, 5 years after operation were significantly different from those before operation ( P<0.05). In the combined group, the DHI of semi-rigid internal fixation segments before operation and 3 months, 1 year, 5 years after operation were 37.8%±7.6%, 37.9%±7.4%, 36.5%±6.9% and 36.0%±7.1% respectively ( P>0.05); The IFH of semi-rigid internal fixation segments before operation and 3 months, 1 year, 5 years after operation were 21.5±2.8, 21.4±2.8, 20.4±2.7, 19.4±2.4 mm respectively ( P<0.05); The DHI of the upper segment adjacent to semi-rigid internal fixation before operation and 3 months, 1 year, 5 years after operation were 37.1%±9.3%, 36.8%±9.1%, 35.2%±9.1%, 33.9%±8.8% respectively ( P>0.05); The IFH of the upper segment adjacent to semi-rigid internal fixation before operation and 3 months, 1 year, 5 years after operation were 21.9±3.0, 21.4±3.0, 20.4±2.9, 19.5±2.7 mm, respectively ( P<0.05). The HD of upper vertebral body adjacent to semi-rigid internal fixation before operation and 3 months, 1 year, 5 years after operation were 2.2±0.7, 2.3±0.5, 2.5±0.5, 2.8±0.5 mm respectively ( P<0.05). At the last follow-up, one case of semi-rigid titanium rod fracture, one case of screw loosening at semi-rigid internal fixation segment, three cases with unsatisfied numbness relief, and 2 cases of facet joint spontaneous fusion at semi-rigid fixation segment occurred in the combined group. Conclusion:Waveflex semi-rigid internal fixation can protect the degenerative lumbar intervertebral disc, and delay the degeneration of semi-rigid internal fixation segment and adjacent upper segment after interbody fusion, but long-term follow-up and study are needed.
3.Clinical Efficacy of Liuwei Dihuangwan Combined with Aclasta on Osteoporosis and Effect on Quality of Life
Xu YANG ; Huaxin WANG ; Qian ZHANG ; Guoqiang ZHANG ; Kaiying CUI ; Guoyan LIU
Chinese Journal of Experimental Traditional Medical Formulae 2022;28(14):115-120
ObjectiveTo study the efficacy of Aclasta combined with Liuwei Dihuangwan on osteoporosis and the effect on quality of life. MethodA total of 126 patients with osteoporosis who were treated in the Affiliated Hospital of Shandong University of Traditional Chinese Medicine from September 2019 to September 2020 were classified into the observation group and the control group with the randomized double-blind method. The observation group consisted of 60 patients (26 males and 34 females) with the age of 59-85 years old [mean: (72.0 ± 6.5) years old]. The control group was composed of 66 patients (31 males and 35 females), with the age of 62-82 years old [mean: (73.0±8.2) years old]. The control group was treated with Aclasta, and the observation group Aclasta combined with Liuwei Dihuangwan. After treatment, the effective rate of each group was calculated. Bone mineral density (BMD) was measured in both groups before and after treatment, and serological parameters calcium (Ca), total 25 (OH) vitamin D3 (VITD-T), osteocalcin (OC), serum alkaline phosphatase (ALP), parathyroid hormone (PTH), β-collagen special sequence (β-CTX), and total procollagen 1 N-terminal propeptide (T-P1NP) were also measured. Visual Analogue Scale (VAS) score, Japanese Orthopaedic Association (JOA) score, and Oswestry Disability Index (ODI) score were evaluated. On this basis, the effect was compared between the two groups. ResultThe indexes were insignificantly different between the two groups before treatment. After 6 months of treatment, the two groups showed decrease in VAS score and ODI score (P<0.01), increase in JOA score (P<0.01), BMD of lumbar spine and hip joint, elevation of Ca, VITD-T, OC, ALP, and PTH (P<0.05, P<0.01), and decrease of β-CTX (P<0.01) as compared with before treatment. The level of T-P1NP dropped in the observation group after treatment (P<0.01).After treatment, the total effective rate of the observation group was 88.3% (53/60), as compared with the 74.2% (49/66) in the control group (χ2=4.047, P<0.05). Moreover, after treatment, the observation group demonstrated higher levels of BMD, Ca, VITD-T, OC, and PTH (P<0.05), lower levels of T-P1NP (P<0.05), lower VAS score (P<0.01), and higher JOA score (P<0.05) than the control group, but the ODI score was insignificantly different from that in the control group. ConclusionAclasta combined with Liuwei Dihuangwan is effective on osteoporosis, without increasing the incidence of adverse reactions. In addition, the combination can alleviate pain and improve the quality of life of osteoporosis patients.